Home › Funds › PRELUDE CAPITAL MANAGEMENT, LLC › CROX
PRELUDE CAPITAL MANAGEMENT, LLC position in CROX
CROCS INC · Consumer Discretionary
PRELUDE CAPITAL MANAGEMENT, LLC reported holding 50,758 shares of CROX (CROCS INC) in its Q3 2026 13F filing — a position valued at US$6.0M, representing 0.48% of its reported portfolio and ranking #30 among its reported holdings. PRELUDE CAPITAL MANAGEMENT, LLC has disclosed CROX holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PRELUDE CAPITAL MANAGEMENT, LLC's CROX position evolved
PRELUDE CAPITAL MANAGEMENT, LLC first disclosed a stake in CROX in Q3 2023 at 43,488 shares (US$3.8M). The position peaked in Q3 2026 at 50,758 shares, worth US$6.0M. Across 8 filings, PRELUDE CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 50,758 shares valued at US$6.0M — an increase of 5,220 shares quarter over quarter.. Notable position changes include a 58% trim in Q4 2023 (shares rose 54% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 43.49K | $3.84M | New |
| Q4 2023 | 18.27K | $1.71M | Reduce |
| Q1 2024 | 22.80K | $3.28M | Add |
| Q4 2024 | 2.41K | $264.30K | New |
| Q3 2025 | 2.48K | $207.54K | New |
| Q1 2026 | 56.74K | $4.71M | New |
| Q2 2026 | 45.54K | $5.49M | Reduce |
| Q3 2026 | 50.76K | $5.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CROX and 13F data
CROX (CROCS INC) is a Consumer Discretionary company. 28 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Patient Capital Management, LLC (US$85.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CROX
- Himalaya Capital 887.09K sh · $107.02M · Q2 2026
- No Street GP LP 820.00K sh · $98.92M · Q2 2026
- Patient Capital Management, LLC 730.95K sh · $85.75M · Q3 2026
- Smead Capital Management, Inc. 709.82K sh · $83.27M · Q3 2026
- DME Capital Management, LP 669.14K sh · $80.73M · Q2 2026
- WIT Partners Advisory Pte. Ltd. 632.81K sh · $74.24M · Q3 2026
- Punch Card Management L.P. 577.17K sh · $69.63M · Q2 2026
- Evercore Wealth Management, LLC 581.27K sh · $68.19M · Q3 2026
More on PRELUDE CAPITAL MANAGEMENT, LLC
FAQ
How long has PRELUDE CAPITAL MANAGEMENT, LLC held CROX?
PRELUDE CAPITAL MANAGEMENT, LLC has disclosed CROX holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
What is PRELUDE CAPITAL MANAGEMENT, LLC's current position in CROX?
As of Q3 2026, PRELUDE CAPITAL MANAGEMENT, LLC holds 50.76K shares of CROX (CROCS INC), valued at $5.95M, representing 0.48% of its reported portfolio and ranking #30.
Has PRELUDE CAPITAL MANAGEMENT, LLC been buying or selling CROX?
In the latest 13F filing (Q3 2026), PRELUDE CAPITAL MANAGEMENT, LLC increased its position in CROX. The position peaked in Q3 2026 at 50.76K shares.
Which other funds hold CROX?
Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Patient Capital Management, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.